We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Measurment of GFR by Nasal Sensors

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01274169
First Posted: January 11, 2011
Last Update Posted: January 11, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Rambam Health Care Campus
  Purpose
to measure kidney function by measuring blood creatinine and to compare it to the measurment of GFR by Nanotechnology

Condition
Measure GFR by Nasal Sensor

Study Type: Observational

Further study details as provided by Rambam Health Care Campus:

Study Start Date: March 2008
Estimated Study Completion Date: March 2010
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
volunteers subjects with different stages of CKD
Criteria

Inclusion Criteria:

adults between 18-70 yrs

Exclusion Criteria:

subject under 18

  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: Ministry of health israel
ClinicalTrials.gov Identifier: NCT01274169     History of Changes
Other Study ID Numbers: NANOCTIL
First Submitted: January 10, 2011
First Posted: January 11, 2011
Last Update Posted: January 11, 2011
Last Verified: February 2008